Apparatus and method for using an ultrasonic probe to clear a vascular access device

• US 20030236539A1
• Filed: 03/25/2003
• Published: 12/25/2003
• Est. Priority Date: 10/05/1999
• Status: Abandoned Application

• Current Assignee: Cybersonics, Inc
• Original Assignee: OmniSonics Medical Technologies, Inc.
• Inventors: Colgan, Peter C., Rabiner, Robert A., Robertson, Roy M., Hare, Bradley A., Marciante, Rebecca I., Varady, Mark J., Ranucci, Kevin J., Prasad, Janniah S., Talbot, Scott A.
• Application Number:
  US10/396,923
• Publication Number:
  US 20030236539A1
• Time in Patent Office: Days
• US Class Current: 606/159
• CPC Class Codes: A61B 17/22012 in direct contact with, or very close to, the obstruction or concrement for removing obstructions in blood vessels by laser A61B18/245
• CPC Class Codes: A61B 2017/00137 Details of operation mode
• CPC Class Codes: A61B 2017/00274 Prostate operation, e.g. prostatectomy, turp, bhp treatment
• CPC Class Codes: A61B 2017/22002 preventing restenosis
• CPC Class Codes: A61B 2017/22007 Cavitation or pseudocavitation, i.e. creation of gas bubbles generating a secondary shock wave when collapsing
• CPC Class Codes: A61B 2017/22008 used or promoted
• CPC Class Codes: A61B 2017/22015 with details of the transmission member
• CPC Class Codes: A61B 2017/22018 segmented along its length
• CPC Class Codes: A61B 2017/22051 with an inflatable part, e.g. balloon, for positioning, blocking, or immobilisation A61B2017/22048, A61B2017/3486 take precedence
• CPC Class Codes: A61B 2017/293 with means preventing relative rotation between the shaft and the actuating rod
• CPC Class Codes: A61B 2017/320069 for ablating tissue
• CPC Class Codes: A61B 2017/320084 Irrigation sleeves
• CPC Class Codes: A61B 2017/320089 node location
• CPC Class Codes: A61B 2018/00547 Prostate
• CPC Class Codes: A61B 2018/00982 combined with or comprising means for visual or photographic inspections inside the body, e.g. endoscopes
• CPC Class Codes: A61B 2217/005 with suction drainage system
• CPC Class Codes: A61B 2217/007 with irrigation system
• CPC Class Codes: A61N 2007/0008 Destruction of fat cells
• CPC Class Codes: A61N 7/022 intracavitary

Abstract

The present invention provides an apparatus and a method for using an ultrasonic probe to remove an occlusion in vascular access devices including fistulas, grafts, catheters and subcutaneous access devices. The ultrasonic probe is inserted into the vascular access device and a section of a longitudinal axis of the ultrasonic probe engages the occlusion. A transducer transmits an ultrasonic energy from an ultrasonic energy source that produces a transverse ultrasonic vibration along the longitudinal axis of the ultrasonic probe. The transverse ultrasonic vibration of the ultrasonic probe provides a plurality of transverse anti-nodes along a portion of the longitudinal axis of the ultrasonic probe that cause a cavitation in a medium in communication with the ultrasonic probe to ablate the occlusion.

Claims

1. An ultrasonic medical device for ablating an occlusion in a vascular access device comprising:

an ultrasonic probe having a proximal end, a distal end and a longitudinal axis therebetween;

an ultrasonic energy source that produces an ultrasonic energy; and

a transducer for transferring the ultrasonic energy from the ultrasonic energy source to the ultrasonic probe, the transducer having a first end engaging the ultrasonic energy source and a second end engaging the proximal end of the ultrasonic probe,

wherein the ultrasonic energy source produces a transverse ultrasonic vibration along the longitudinal axis of the ultrasonic probe to ablate the occlusion in the vascular access device.

2. The device of claim 1 wherein the vascular access device is selected from a group consisting of a graft, a fistula, a catheter and a subcutaneous access device.

3. The device of claim 1 wherein a length and a cross section of the ultrasonic probe are sized to support the transverse ultrasonic vibration with a plurality of transverse nodes and transverse anti-nodes along a portion of the longitudinal axis of the ultrasonic probe.

4. The device of claim 3 wherein the transverse anti-nodes are points of a maximum transverse energy along the portion of the longitudinal axis of the ultrasonic probe.

5. The device of claim 3 wherein the transverse anti-nodes cause a cavitation in a medium in communication with the ultrasonic probe.

6. The device of claim 3 wherein more than one of the plurality of transverse anti-nodes are in communication with the occlusion.

7. The device of claim 1 wherein the ultrasonic probe is for a single use on a single patient.

8. The device of claim 1 wherein the ultrasonic probe is disposable.

9. The device of claim 1 wherein the occlusion comprises a biological material.

10. An elongated flexible probe for removing an occlusion in a vascular access device comprising:

a proximal end, a distal end and a longitudinal axis therebetween,

wherein the elongated flexible probe supports a transverse ultrasonic vibration along a portion of the longitudinal axis of the elongated flexible probe to remove the occlusion.

11. The device of claim 10 wherein the vascular access device is selected from a group consisting of a graft, a fistula, a catheter and a subcutaneous access device.

12. The device of claim 10 wherein the elongated flexible probe is a wire.

13. The device of claim 10 wherein the elongated flexible probe has a stiffness that gives the elongated flexible probe a flexibility to be articulated in the vascular access device.

14. The device of claim 10 wherein an ultrasonic energy source produces the transverse ultrasonic vibration along the portion of the longitudinal axis of the elongated flexible probe.

15. The device of claim 10 wherein the transverse ultrasonic vibration of the elongated flexible probe provides a plurality of transverse anti-nodes along the portion of the longitudinal axis of the elongated flexible probe.

16. The device of claim 15 wherein the transverse anti-nodes are points of a maximum transverse energy along the portion of the longitudinal axis of the elongated flexible probe.

17. The device of claim 15 wherein the transverse anti-nodes cause a cavitation in a medium in communication with the elongated flexible probe in a direction not parallel to the longitudinal axis of the elongated flexible probe.

18. The device of claim 10 wherein a cross section of the elongated flexible probe has a small profile.

19. The device of claim 10 wherein a diameter of the elongated flexible probe is approximately uniform along the longitudinal axis of the elongated flexible probe.

20. The device of claim 10 wherein a diameter of the elongated flexible probe varies from the proximal end of the elongated flexible probe to the distal end of the elongated flexible probe.

21. The device of claim 10 wherein the occlusion comprises a biological material.

22. A method of removing an occlusion in a vascular access device comprising:

inserting an elongated ultrasonic probe into the vascular access device; and

activating an ultrasonic energy source, wherein the ultrasonic energy source provides an ultrasonic energy to produce a transverse ultrasonic vibration in the elongated ultrasonic probe to remove the occlusion in the vascular access device.

23. The method of claim 22 wherein the vascular access device is selected from a group consisting of a graft, a fistula, a catheter, and a subcutaneous access device.

24. The method of claim 22 wherein a segment of a longitudinal axis of the elongated ultrasonic probe is inserted into the vascular access device.

25. The method of claim 22 wherein the ultrasonic energy source produces the transverse ultrasonic vibration along a portion of a longitudinal axis of the elongated ultrasonic probe.

26. The method of claim 22 wherein the transverse ultrasonic vibration of the elongated ultrasonic probe provides a plurality of transverse anti-nodes along a portion of a longitudinal axis of the elongated ultrasonic probe.

27. The method of claim 26 wherein the transverse anti-nodes are points of a maximum transverse energy along the portion of the longitudinal axis of the elongated ultrasonic probe.

28. The method of claim 26 wherein the transverse anti-nodes cause a cavitation in a medium in communication with the elongated ultrasonic probe in a direction not parallel to the longitudinal axis of the elongated ultrasonic probe.

29. The method of claim 26 wherein more than one of the plurality of transverse antinodes are in communication with the occlusion.

30. The method of claim 22 wherein a length and a cross section of the elongated ultrasonic probe are sized to support the transverse ultrasonic vibration with a plurality of transverse nodes and transverse anti-nodes along a portion of a longitudinal axis of the elongated ultrasonic probe.

31. The method of claim 22 wherein the elongated ultrasonic probe can support the transverse ultrasonic vibration along a portion of a longitudinal axis of the elongated ultrasonic probe to remove the occlusion.

32. The method of claim 22 wherein a first end of a transducer engages the ultrasonic energy source and a second end of the transducer engages a proximal end of the elongated ultrasonic probe.

33. The method of claim 22 wherein a diameter of the elongated ultrasonic probe is approximately uniform along a longitudinal axis of the elongated ultrasonic probe.

34. The method of claim 22 wherein a diameter of the elongated ultrasonic probe varies from a proximal end of the elongated ultrasonic probe to a distal end of the elongated ultrasonic probe.

35. The method of claim 22 wherein a cross section of the elongated ultrasonic probe has a small profile.

36. The method of claim 22 wherein the elongated ultrasonic probe is for a single use on a single patient.

37. The method of claim 22 wherein the elongated ultrasonic probe is disposable.

38. The method of claim 22 wherein the elongated ultrasonic probe has a stiffness that gives the elongated ultrasonic probe a flexibility to be articulated in the vascular access device.

39. The method of claim 22 wherein the occlusion comprises a biological material.

40. A method of ablating an occlusion located in a vascular access device comprising:

inserting a segment of a longitudinal axis of a flexible ultrasonic probe into the vascular access device;

activating an ultrasonic energy source to produce a transverse ultrasonic vibration along the longitudinal axis of the flexible ultrasonic probe; and

moving the segment of the longitudinal axis of the flexible ultrasonic probe within the vascular access device to ablate the occlusion in the vascular access device.

41. The method of claim 40 wherein the longitudinal axis of the flexible ultrasonic probe is rotated within the vascular access device.

42. The method of claim 40 wherein the flexible ultrasonic probe is swept along the occlusion within the vascular access device.

43. The method of claim 40 wherein the flexible ultrasonic probe is moved back and forth along the occlusion within the vascular access device.

44. The method of claim 40 wherein the vascular access device is selected from a group consisting of a graft, a fistula, a catheter, and a subcutaneous access device.

45. The method of claim 40 wherein a transducer transmits an ultrasonic energy to the flexible ultrasonic probe causing a plurality of transverse ultrasonic vibrations along the longitudinal axis of the flexible ultrasonic probe.

46. The method of claim 40 wherein the transverse ultrasonic vibration of the flexible ultrasonic probe provides a plurality of transverse anti-nodes along a portion of the longitudinal axis of the flexible ultrasonic probe.

47. The method of claim 46 wherein the transverse anti-nodes are points of a maximum transverse energy along the portion of the longitudinal axis of the flexible ultrasonic probe.

48. The method of claim 46 wherein the transverse anti-nodes cause a cavitation in a medium in communication with the flexible ultrasonic probe.

49. The method of claim 46 wherein more than one of the plurality of transverse antinodes are in communication with the occlusion.

50. The method of claim 40 wherein a length and a cross section of the flexible ultrasonic probe are sized to support the transverse ultrasonic vibration with a plurality of transverse nodes and transverse anti-nodes along a portion of the longitudinal axis of the flexible ultrasonic probe.

51. The method of claim 40 wherein a first end of a transducer engages the ultrasonic energy source and a second end of the transducer engages a proximal end of the flexible ultrasonic probe.